Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients. We are focused on developing life-changing medicines for people with serious diseases — often with limited or no options — so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again.
Through continued investment in an evolving and growing research and development focus, we seek solutions for rare or complex diseases, and ensure those solutions are available for the often-overlooked patients who need them. Our approach has allowed us to shepherd new medicines to market – from late-stage discovery through clinical development and regulatory approval. All of these advancements are a reflection of our continued investment in an evolving and growing research and development focus.